HEALTHJun 9 · 09:00 UTCNPR NEWSYuki Noguchi

GLP-1s appear to protect against cancer. Researchers are trying to figure out how

Recent studies suggest GLP-1s, weight loss and diabetes drugs, may prevent cancer and slow its progression. While weight loss is known to reduce cancer risks, GLP-1s might act on additional brain and metabolic pathways to achieve this effect.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

GLP-1stopiccancertopicweight losstopicdiabetes drugstopicMichael Silukperson

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

HEALTHJun 9 · 09:00 UTC
GLP-1s appear to protect against cancer. Researchers are trying to figure out how
HEALTHMay 21 · 21:02 UTC
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
HEALTHMay 28 · 15:03 UTC
GLP-1 drugs linked to major slowdown in breast cancer, prostate cancer and more: new study
HEALTHJun 6 · 13:28 UTC
Ozempic and similar weight-loss drugs linked to 30% lower breast cancer risk